Compounds > isoxazoles
Page last updated: 2024-08-21

isoxazoles and Heritable Pulmonary Arterial Hypertension

isoxazoles has been researched along with Heritable Pulmonary Arterial Hypertension in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Derk, CT; Shetty, N1
Galiè, N; Gibbs, JS; Hoeper, MM; Simonneau, G1
Fisher, AJ; Johnson, MK; Kirkham, N; Lee, WT; Lordan, JL; Peacock, AJ1
Galiè, N; Gibbs, R; Hoeper, MM; Simon, J; Simonneau, G1
Safdar, Z1
French, B; Gabler, NB; Halpern, SD; Kawut, SM; Liu, Z; Palevsky, HI; Strom, BL; Taichman, DB1
Hintz, E; Klein, R; Staehler, G1
Blenkhorn, F; Eisenberg, MJ; Fox, B; Hirsch, AM; Joyal, D; Langleben, D; Lesenko, L; Schlesinger, RD1
Luo, N; Ryan, JJ1

Reviews

1 review(s) available for isoxazoles and Heritable Pulmonary Arterial Hypertension

ArticleYear
Endothelin receptor antagonists as disease modifiers in systemic sclerosis.
    Inflammation & allergy drug targets, 2011, Volume: 10, Issue:1

    Topics: Animals; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Endothelins; Familial Primary Pulmonary Hypertension; Fibrosis; Humans; Hypertension, Pulmonary; Isoxazoles; Phenylpropionates; Pyridazines; Receptors, Endothelin; Scleroderma, Systemic; Sulfonamides; Thiophenes; Treatment Outcome

2011

Trials

1 trial(s) available for isoxazoles and Heritable Pulmonary Arterial Hypertension

ArticleYear
Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.
    Chest, 2012, Volume: 141, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bosentan; Child; Double-Blind Method; Endothelin Receptor Antagonists; Ethnicity; Exercise Test; Familial Primary Pulmonary Hypertension; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Phenylpropionates; Prevalence; Prospective Studies; Pulmonary Wedge Pressure; Pyridazines; Sex Factors; Sulfonamides; Thiophenes; Treatment Outcome; United States; Walking; Young Adult

2012

Other Studies

7 other study(ies) available for isoxazoles and Heritable Pulmonary Arterial Hypertension

ArticleYear
Liver toxicity of sitaxentan in pulmonary arterial hypertension.
    The European respiratory journal, 2011, Volume: 37, Issue:2

    Topics: Chemical and Drug Induced Liver Injury; Contraindications; Endothelin Receptor Antagonists; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Isoxazoles; Liver Failure; Practice Guidelines as Topic; Thiophenes

2011
Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension.
    The European respiratory journal, 2011, Volume: 37, Issue:2

    Topics: Chemical and Drug Induced Liver Injury; Contraindications; Endothelin A Receptor Antagonists; Familial Primary Pulmonary Hypertension; Fatal Outcome; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Jaundice; Liver Failure, Acute; Piperazines; Purines; Sildenafil Citrate; Sulfones; Thiophenes; Vasodilator Agents; Young Adult

2011
Liver toxicity of sitaxentan in pulmonary arterial hypertension.
    European heart journal, 2011, Volume: 32, Issue:4

    Topics: Antihypertensive Agents; Chemical and Drug Induced Liver Injury; Early Termination of Clinical Trials; Endothelin Receptor Antagonists; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Isoxazoles; Safety-Based Drug Withdrawals; Thiophenes

2011
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension.
    Vascular health and risk management, 2011, Volume: 7

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Substitution; Dyspnea; Edema; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Liver Function Tests; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen; Phenylpropionates; Pyridazines; Retrospective Studies; Texas; Thiophenes; Time Factors; Treatment Outcome; Walking

2011
Exacerbation of AIH in a patient with an AIH/systemic sclerosis overlap syndrome and pulmonary arterial hypertension treated with the endothelin-1 receptor antagonist sitaxentan.
    BMJ case reports, 2012, Jul-13, Volume: 2012

    Topics: Autoantibodies; Autoantigens; Disease Progression; Endothelin A Receptor Antagonists; Familial Primary Pulmonary Hypertension; Female; Hepatitis, Autoimmune; Humans; Hypertension, Pulmonary; Isoxazoles; Middle Aged; Scleroderma, Systemic; Thiophenes; Treatment Outcome

2012
Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension.
    The Canadian journal of cardiology, 2013, Volume: 29, Issue:6

    Topics: Administration, Oral; Aged; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Middle Aged; Phenylpropionates; Pulmonary Wedge Pressure; Pyridazines; Retrospective Studies; Sulfonamides; Thiophenes; Treatment Outcome; Vascular Resistance

2013
Transitioning between endothelin receptor blockers: monitoring to ensure a smooth transition.
    The Canadian journal of cardiology, 2013, Volume: 29, Issue:6

    Topics: Bosentan; Endothelin Receptor Antagonists; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Phenylpropionates; Pulmonary Wedge Pressure; Pyridazines; Sulfonamides; Thiophenes; Vascular Resistance

2013